OUR VISION
Supply chain oversight partner.
To be the supply chain oversight partner of choice for International Pharma /Biopharma companies for product release into Europe.
MIAS INSIGHT
Latest Market & MIAS Updates.
The Role of GDP in preventing falsified Medicines
The function of the Responsible Person (RP) in the context of pharmaceutical wholesale distribution, as outlined by Good Distribution Practice (GDP) plays
UK Requirements for a RP to be on a Wholesale Distribution Authorisation (WDA)
The Responsible Person (RP) on a UK Wholesale Distribution Authorisation (WDA) for pharmaceuticals has specific responsibilities to ensure that imported pharmaceutical products
ATMPs and why you should use MIAS Pharma as your Batch Certification partner of choice
Advanced therapy medicinal products ( (ATMPs) are medicines that are based on genes, tissues or cells which offer groundbreaking new opportunities for the